What’s Actually Driving Your Testosterone Down? | Signal Ep 3

Most cases of low testosterone in modern men are not a problem with the testes. The number is downstream of body composition, sleep, and energy availability. The wellness-clinic algorithm walks past every one of them.

Jordan and Austin walk through what actually drives men’s testosterone down, the mechanisms behind it, and the modifiable levers that bring it back up. MOSH, the leptin and Kisspeptin pathway, the aromatase loop, the sleep apnea picture most clinics never ask about, the GLP-1 and weight-loss data on testosterone recovery, the low energy availability case that hits high-volume lifters harder than they realize, and the closing question of when a standard-dose TRT prescription actually functions as a PED.

This is Episode 3 of our four-part Signal book launch series. Mark, the patient we have been threading from Episode 1, finally gets his diagnosis revealed.

Timestamps

• 00:00 The 9x stat and Mark's diagnosis revealed
•  02:10 How body fat suppresses testosterone (MOSH)
•  07:26 Primary vs secondary causes, and Klinefelter
•  11:35 Leptin and the Kisspeptin pathway
•  14:38 Mark: the body-composition picture
•  16:10 The 40-inch-waist case
•  20:01 Weight loss, GLP-1s, and does Ozempic raise testosterone?
•  24:21 T4DM: adding testosterone to lifestyle
•  28:35 Sleep, OSA, and Mark's diagnosis
•  38:39 TRT in untreated sleep apnea
•  41:47 Can you train your testosterone down? (LEA / EHMC)
•  50:12 Replacement dose vs PED
•  55:47 Four takeaways
•  57:46 Episode 4 preview and book pre-order

What we cover:

•         How body fat suppresses testosterone at two different points in the HPG axis, and why the loop is self-reinforcing

•         The leptin and Kisspeptin pathway most clinics never address

•         Mark’s case: a 45-year-old with a 240 ng/dL afternoon draw, no workup, and an immediate prescription

•         Primary versus secondary causes, and why Klinefelter syndrome is the under-recognized one to not miss

•         Weight loss dose-response: how much testosterone climbs on lifestyle alone, with GLP-1 agonists, and after bariatric surgery

•         T4DM: why adding testosterone to a structured weight-loss program produced no extra quality-of-life benefit over placebo

•         One week of sleep restriction drops testosterone by about 15 percent in healthy young men; eight days of military field exercises drop it by 50 percent

•         Why CPAP for obstructive sleep apnea reliably improves symptoms but does not always move the lab number

•         The opposite extreme: low energy availability, relative energy deficiency in sport, and the exercise-hypogonadal male condition

•         The lifter calculus: when a textbook replacement dose is functionally a PED in a chronically underfueled trainee

Resources mentioned:

• Signal book pre-order: https://barbellmedicine.com/signal
•  Training Plateau Action Plan (free): https://www.barbellmedicine.com/training-plateau-action-plan/
•  Barbell Medicine programs and coaching: https://www.barbellmedicine.com/
•  Episode 1 (Is the Testosterone Crisis Real?)
•  Episode 2 (Is Your Testosterone Actually Low?
• 
  

Referenced studies:

Wu F.C.W. et al. 2010. Identification of late-onset hypogonadism in middle-aged and elderly men (EMAS). N Engl J Med 363(2):123-135.

 https://pubmed.ncbi.nlm.nih.gov/20554979/

 Travison T.G. et al. 2011. The natural history of symptomatic androgen deficiency in men. J Am Geriatr Soc.

 https://pubmed.ncbi.nlm.nih.gov/18454751/

 Corona G. et al. 2013. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: systematic review and meta-analysis. Eur J Endocrinol 168(6):829-843.

 https://pubmed.ncbi.nlm.nih.gov/23482592/

 Kounatidis D. et al. 2025. The impact of GLP-1 receptor agonists on erectile function. Biomolecules 15(9):1284.

 https://doi.org/10.3390/biom15091284

 Grossmann M. et al. 2024. Testosterone treatment, weight loss, and health-related quality of life and psychosocial function in men: 2-year RCT (T4DM QoL arm). J Clin Endocrinol Metab 109(8):2019-2028.

 https://pubmed.ncbi.nlm.nih.gov/38311835/

 Leproult R., Van Cauter E. 2011. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 305(21):2173-2174.

 https://pubmed.ncbi.nlm.nih.gov/21632481/

 Penev P.D. 2007. Association between sleep and morning testosterone levels in older men. Sleep 30(4):427-432.

 https://pubmed.ncbi.nlm.nih.gov/17520785/

 Wittert G. 2014. The relationship between sleep disorders and testosterone in men. Asian J Androl 16(2):262-265.

 https://pubmed.ncbi.nlm.nih.gov/24435056/

 Alemany J.A. et al. 2008. Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity. J Appl Physiol 105(1):58-64.

 https://pubmed.ncbi.nlm.nih.gov/18450989/

 Mountjoy M., Sundgot-Borgen J.K., Burke L.M. et al. 2018. IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update. Br J Sports Med 52:687-697.

 https://pubmed.ncbi.nlm.nih.gov/29773536/

 Areta J.L. et al. 2021. Low energy availability: history, definition and evidence of its endocrine, metabolic and physiological effects in prospective studies in females and males. Eur J Appl Physiol 121(1):1-21.

 https://pubmed.ncbi.nlm.nih.gov/33095376/

 Mäestu J. et al. 2010. Anabolic and catabolic hormones and energy balance of the male bodybuilders during the preparation for the competition. J Strength Cond Res 24(4):1074-1081.

 https://pubmed.ncbi.nlm.nih.gov/20300023/

 Hooper D.R. et al. 2018. Treating exercise-associated low testosterone (EHMC). Phys Sportsmed 46(4):427-434.

 https://pubmed.ncbi.nlm.nih.gov/30074435/

 Hackney A.C. 2020. Hypogonadism in exercising males: dysfunction or adaptive-regulatory adjustment? Front Endocrinol 11:11.

 https://pubmed.ncbi.nlm.nih.gov/32082252/